Oracle Investment Management as of March 31, 2018
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 19 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Quidel Corporation | 40.1 | $131M | 2.5M | 51.81 | |
| Tesaro | 14.8 | $48M | 845k | 57.14 | |
| Pacific Biosciences of California (PACB) | 6.0 | $20M | 9.5M | 2.05 | |
| Amarin Corporation (AMRN) | 4.8 | $16M | 5.2M | 3.01 | |
| Mazor Robotics Ltd. equities | 4.6 | $15M | 246k | 61.36 | |
| Adaptimmune Therapeutics (ADAP) | 4.6 | $15M | 1.3M | 11.23 | |
| Vermillion | 4.1 | $13M | 9.8M | 1.36 | |
| Biolase Technology | 3.9 | $13M | 31M | 0.41 | |
| Opko Health (OPK) | 3.6 | $12M | 3.7M | 3.17 | |
| Accelr8 Technology Corporation | 2.7 | $8.7M | 5.0M | 1.76 | |
| shares Agenus | 2.2 | $7.3M | 1.5M | 4.71 | |
| Epizyme | 2.1 | $7.0M | 396k | 17.75 | |
| Arena Pharmaceuticals | 2.1 | $6.9M | 175k | 39.50 | |
| Contrafect | 1.6 | $5.2M | 3.2M | 1.63 | |
| Soleno Therapeutics | 1.3 | $4.3M | 2.4M | 1.81 | |
| Aduro Biotech | 0.7 | $2.2M | 239k | 9.30 | |
| Biogen Idec (BIIB) | 0.5 | $1.7M | 6.4k | 273.87 | |
| Bristol Myers Squibb (BMY) | 0.4 | $1.2M | 777k | 1.54 | |
| Second Sight Med Prods | 0.0 | $98k | 51k | 1.93 |
